![George Ji](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Patrick Lu | M | 68 |
Sirnaomics, Inc.
![]() Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD.
Guangzhou Natai Biomedical Technology Co., Ltd.
![]() Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012. | 17 ans |
David Evans | M | 61 |
Sirnaomics, Inc.
![]() Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | 17 ans |
Danny Tang | M | - |
Guangzhou Natai Biomedical Technology Co., Ltd.
![]() Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012. | 12 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Marc Lemaitre | M | - |
Sirnaomics, Inc.
![]() Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 3 | 75,00% |
Chine | 2 | 50,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations